Developments at Cymaris Labs & Columbus Nanoworks

  • September 2019 - NCI Phase I SBIR Contract Award

Columbus Nanoworks awarded Phase I contract from the NIH National Cancer Institute (NCI) to develop the use of fluorescent nanodiamonds for cancer immunotherapy applications.  This award is part of the NCI Moonshot Initiative.

  • June 1, 2019 - NIGMS Phase I SBIR Grant Completed

Columbus Nanoworks successfully completes NIGMS Phase I grant.

  • May 1, 2018 - NIGMS Phase I SBIR Grant Award

Columbus Nanoworks awarded Phase I contract from the NIH National Institute of General Medical Sciences (NIGMS) to develop an enzymatic method for attachment of proteins to fluorescent nanodiamond surfaces.

  • April 30, 2018 - NHLBI Phase II SBIRContract Completed

Columbus Nanoworks successfully completes NHLBI Phase II contract.

  • July 31, 2015 - NHLBI Phase II SBIR Contract Award

Columbus Nanoworks awarded Phase I contract from the NIH National Heart, Lung, Blood Institute (NHLBI) to continue development of fluorescent nanodiamonds for in vitro and in vivo biological imaging.

  • August 2014 - NHLBI Phase I SBIR Contract Completed

Columbus Nanoworks successfully completes NHLBI Phase I contract.

  • September 2013 - NHLBI Phase I SBIR Contract Award

Columbus Nanoworks awarded Phase I contract from the NIH National Heart, Lung, Blood Institute (NHLBI) to develop fluorescent nanodiamonds for in vitro and in vivo biological imaging.